Bausch + Lomb Corporation (TSX:BLCO)

Market Cap	8.26B
Revenue (ttm)	6.93B
Net Income (ttm)	-424.83M
Shares Out	n/a
EPS (ttm)	-1.20
PE Ratio	n/a
Forward PE	19.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,051
Average Volume	1,700
Open	23.66
Previous Close	23.54
Day's Range	22.69 - 23.90
52-Week Range	14.56 - 29.30
Beta	0.63
RSI	63.17
Earnings Date	Feb 18, 2026

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during heal...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1853
• Employees: 13,500
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: BLCO

Financial Performance

In 2024, Bausch + Lomb's revenue was $4.79 billion, an increase of 15.56% compared to the previous year's $4.15 billion. Losses were -$317.00 million, 21.9% more than in 2023.

Financial numbers in USD